<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03411317</url>
  </required_header>
  <id_info>
    <org_study_id>2017/081/HP</org_study_id>
    <nct_id>NCT03411317</nct_id>
  </id_info>
  <brief_title>Aortic Stenosis: Determinants of Progression, Severity and Left Ventricular Remodeling</brief_title>
  <acronym>AS-PROGRESSION</acronym>
  <official_title>Aortic Stenosis: Determinants of Progression, Severity and Left Ventricular Remodeling (AS-PROGRESSION)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aortic stenosis (AS) is the most frequent valvulopathy in Western countries. The prevalence
      of AS is constantly increasing due to the aging of the population. Although significant
      progress has been made in understanding the pathophysiological mechanisms underlying the
      onset and progression of AS, there is no medical treatment to slow or prevent its
      progression. The only treatment available is Aortic Valve Replacement (AVR) performed by
      surgery or by catheterization (TAVI).

      AS is associated with an increase of post-load which leads the left ventricular myocardium to
      hypertrophy. Associated with hypertrophy, myocardial fibrosis will gradually develop. Despite
      interesting data, many unknowns persist and remain to be identified.

      The aim of the study is to evaluate prospectively the progression and impact of AS in 500
      patients using clinical, biological, echocardiographic and MRI parameters performed annually.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 11, 2017</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite primary endpoint: haemodynamic and anatomical progression of Aortic Stenosis</measure>
    <time_frame>Year 1</time_frame>
    <description>CT scan and MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Composite primary endpoint: haemodynamic and anatomical progression of Aortic Stenosis</measure>
    <time_frame>Year 2</time_frame>
    <description>CT scan and MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Composite primary endpoint: haemodynamic and anatomical progression of Aortic Stenosis</measure>
    <time_frame>Year 3</time_frame>
    <description>CT scan and MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Composite primary endpoint: haemodynamic and anatomical progression of Aortic Stenosis</measure>
    <time_frame>Year 4</time_frame>
    <description>CT scan and MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determinants of left ventricular remodeling</measure>
    <time_frame>Year 1</time_frame>
    <description>MRI and echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determinants of left ventricular remodeling</measure>
    <time_frame>Year 2</time_frame>
    <description>MRI and echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determinants of left ventricular remodeling</measure>
    <time_frame>Year 3</time_frame>
    <description>MRI and echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determinants of left ventricular remodeling</measure>
    <time_frame>Year 4</time_frame>
    <description>MRI and echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression of left ventricular remodeling</measure>
    <time_frame>Year 1</time_frame>
    <description>MRI and echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression of left ventricular remodeling</measure>
    <time_frame>Year 2</time_frame>
    <description>MRI and echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression of left ventricular remodeling</measure>
    <time_frame>Year 3</time_frame>
    <description>MRI and echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression of left ventricular remodeling</measure>
    <time_frame>Year 4</time_frame>
    <description>MRI and echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic value of ventricular mass, type of ventricular remodeling and fibrosis in Aortic Stenosis</measure>
    <time_frame>Year 1</time_frame>
    <description>Occurrence of clinical events, MRI, CT scan and echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic value of ventricular mass, type of ventricular remodeling and fibrosis in Aortic Stenosis</measure>
    <time_frame>Year 2</time_frame>
    <description>Occurrence of clinical events, MRI, CT scan and echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic value of ventricular mass, type of ventricular remodeling and fibrosis in Aortic Stenosis</measure>
    <time_frame>Year 3</time_frame>
    <description>Occurrence of clinical events, MRI, CT scan and echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic value of ventricular mass, type of ventricular remodeling and fibrosis in Aortic Stenosis</measure>
    <time_frame>Year 4</time_frame>
    <description>Occurrence of clinical events, MRI, CT scan and echocardiography</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with at least moderate aortic stenosis and in whom an intervention is not
        programmed or indicated
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aortic stenosis (peak aortic valve velocity (Vmax) ≥2.5m/s )

        Exclusion Criteria:

          -  rheumatismal or congenital aortic stenosis

          -  aortic insufficiency (grade &gt;= 2/4)

          -  Associated valvulopathy (grade &gt;= 2/4)

          -  Angina, syncope, dyspnea NYHA 3-4

          -  Heart failure antecedent

          -  Myocardial infarction antecedent

          -  Severe renal failure

          -  indication of Aortic Valve Replacement (Surgery or TAVI)

          -  Cardiac surgery (Aorta abdominal) antecedent

          -  Complex congenital cardiopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helene Eltchaninoff, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Helene Eltchaninoff, Pr</last_name>
    <phone>+33232888232</phone>
    <email>helene.eltchaninoff@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Delphine Béziau-Gasnier, PhD</last_name>
    <phone>+33232886766</phone>
    <email>delphine.beziau-gasnier@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UH Rouen</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène Eltchaninoff, MD</last_name>
      <phone>+33232888232</phone>
      <email>helene.eltchaninoff@chu-rouen.fr</email>
    </contact>
    <contact_backup>
      <last_name>Delphine Beziau-Gasnier, PhD</last_name>
      <phone>+33232886766</phone>
      <email>delphine.beziau-gasnier@chu-rouen.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2017</study_first_submitted>
  <study_first_submitted_qc>January 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2018</study_first_posted>
  <last_update_submitted>January 24, 2018</last_update_submitted>
  <last_update_submitted_qc>January 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic stenosis</keyword>
  <keyword>progression</keyword>
  <keyword>Left ventricular remodeling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Disease Progression</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Ventricular Remodeling</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

